Patent details

Basic Information

Publication number:

EP2768524

PCT Application Number:

DK2012050386

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP127804086

PCT Publication Number:

WO2013056716

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PD-L1 BASED IMMUNOTHERAPY

French Title of Invention:

IMMUNOTHÉRAPIE PAR PD-L1

German Title of Invention:

PD-L1 IMMUNTHERAPIE

SPC Number:

Dates

Filing date:

17/10/2012

Grant date:

04/05/2022

EP Publication Date:

27/08/2014

PCT Publication Date:

25/04/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/05/2022

EP B1 Publication Date:

04/05/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

17/10/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/04/2022

 

 

Name:

IO Biotech ApS

Address:

Ole Maaløes Vej 3, 2200 Copenhagen N, Denmark (DK)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

10/06/2022

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

Name:

ANDERSEN, Mads Hald

Address:

Denmark (DK)

Priority

Priority Number:

201170574 P

Priority Date:

17/10/2011

Priority Country:

Denmark (DK)

Classification

IPC classification:

A61K 39/00; A61P 35/00; C07K 14/705;

Publication

European Patent Bulletin

Issue number:

202218

Publication date:

04/05/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

02/11/2026

Annual Fee Number:

15

Annual Fee Amount:

213 Euro

Expected Payer:

Last Annual Fee Payment Date:

16/10/2025

Last Annual Fee Paid Number:

14

Last Annual Fee Paid Amount:

198 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
10/06/2022	Power Of Attorney	1
10/06/2022	Outgoing Correspondence	1